Problem statement: Answer the multiple choice question.
Question: Which compound exhibits a 11.979% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a: CN(C)c1ccc(CNC(=O)CCNS(=O)(=O)c2cc(Br)cnc2N)cc1
b: COC(=O)c1ccc(NC(=S)N(Cc2cccnc2)Cc2ccco2)cc1
c: COCCCNS(=O)(=O)c1cc2c3c(c1)C(C)C(=O)N3CCC2
d: O=C(CC1CC2CCC1C2)N1CCN(S(=O)(=O)c2ccccc2F)CC1
Answer: a. CN(C)c1ccc(CNC(=O)CCNS(=O)(=O)c2cc(Br)cnc2N)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)c1ccc(CNC(=O)CCNS(=O)(=O)c2cc(Br)cnc2N)cc1
CN(C)c1ccc(CNC(=O)CCNS(=O)(=O)c2cc(Br)cnc2N)cc1
3-[(2-amino-5-bromopyridin-3-yl)sulfonylamino]-N-[[4-(dimethylamino)phenyl]methyl]propanamide